載入...
Toxicity of Cancer Therapy: What the Cardiologist Needs to Know about Angiogenesis Inhibitors
Clinical outcomes for patients with a wide range of malignancies have improved substantially over the last two decades. Tyrosine kinase inhibitors (TKI) are potent signalling cascade inhibitors and have been responsible for significant advances in cancer therapy. By inhibiting vascular endothelial g...
Na minha lista:
| 發表在: | Heart |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6268130/ https://ncbi.nlm.nih.gov/pubmed/30228246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2018-313726 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|